Global Artificial Blood Substitute Market Insights and Forecast to 2031

Report ID: 885313 | Published Date: Oct 2024 | No. of Page: 115 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Artificial Blood Substitute Product Introduction
    1.2 Market by Type
        1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type
        1.4.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
        1.4.3 Hemoglobin-based Oxygen Carrier (HBOC)
    1.3 Market by Application
        1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application
        1.3.2 Military
        1.3.3 Civil
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Artificial Blood Substitute Sales Estimates and Forecasts 2016-2027
    2.2 Global Artificial Blood Substitute Revenue Estimates and Forecasts 2016-2027
    2.3 Global Artificial Blood Substitute Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Artificial Blood Substitute Regions by Sales
        2.4.1 Global Top Artificial Blood Substitute Regions by Sales (2016-2021)
        2.4.2 Global Top Artificial Blood Substitute Regions by Sales (2022-2027)
    2.5 Global Top Artificial Blood Substitute Regions by Revenue
        2.5.1 Global Top Artificial Blood Substitute Regions by Revenue (2016-2021)
        2.5.2 Global Top Artificial Blood Substitute Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Artificial Blood Substitute Sales by Manufacturers
        3.1.1 Global Top Artificial Blood Substitute Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Artificial Blood Substitute Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Sales in 2020
    3.2 Global Artificial Blood Substitute Revenue by Manufacturers
        3.2.1 Global Top Artificial Blood Substitute Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Artificial Blood Substitute Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2020
    3.3 Global Artificial Blood Substitute Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Artificial Blood Substitute Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Artificial Blood Substitute Sales by Type
        4.1.1 Global Artificial Blood Substitute Historical Sales by Type (2016-2021)
        4.1.2 Global Artificial Blood Substitute Forecasted Sales by Type (2022-2027)
        4.1.3 Global Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    4.2 Global Artificial Blood Substitute Revenue by Type
        4.2.1 Global Artificial Blood Substitute Historical Revenue by Type (2016-2021)
        4.2.2 Global Artificial Blood Substitute Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    4.3 Global Artificial Blood Substitute Price by Type
        4.3.1 Global Artificial Blood Substitute Price by Type (2016-2021)
        4.3.2 Global Artificial Blood Substitute Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Artificial Blood Substitute Sales by Application
        5.1.1 Global Artificial Blood Substitute Historical Sales by Application (2016-2021)
        5.1.2 Global Artificial Blood Substitute Forecasted Sales by Application (2022-2027)
        5.1.3 Global Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    5.2 Global Artificial Blood Substitute Revenue by Application
        5.2.1 Global Artificial Blood Substitute Historical Revenue by Application (2016-2021)
        5.2.2 Global Artificial Blood Substitute Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    5.3 Global Artificial Blood Substitute Price by Application
        5.3.1 Global Artificial Blood Substitute Price by Application (2016-2021)
        5.3.2 Global Artificial Blood Substitute Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Artificial Blood Substitute Market Size by Type
        6.1.1 North America Artificial Blood Substitute Sales by Type (2016-2027)
        6.1.2 North America Artificial Blood Substitute Revenue by Type (2016-2027)
    6.2 North America Artificial Blood Substitute Market Size by Application
        6.2.1 North America Artificial Blood Substitute Sales by Application (2016-2027)
        6.2.2 North America Artificial Blood Substitute Revenue by Application (2016-2027)
    6.3 North America Artificial Blood Substitute Market Size by Country
        6.3.1 North America Artificial Blood Substitute Sales by Country (2016-2027)
        6.3.2 North America Artificial Blood Substitute Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Artificial Blood Substitute Market Size by Type
        7.1.1 Europe Artificial Blood Substitute Sales by Type (2017-2027)
        7.1.2 Europe Artificial Blood Substitute Revenue by Type (2017-2027)
    7.2 Europe Artificial Blood Substitute Market Size by Application
        7.2.1 Europe Artificial Blood Substitute Sales by Application (2017-2027)
        7.2.2 Europe Artificial Blood Substitute Revenue by Application (2017-2027)
    7.3 Europe Artificial Blood Substitute Market Size by Country
        7.3.1 Europe Artificial Blood Substitute Sales by Country (2017-2027)
        7.3.2 Europe Artificial Blood Substitute Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Artificial Blood Substitute Market Size by Type
        8.1.1 Asia Pacific Artificial Blood Substitute Sales by Type (2018-2027)
        8.1.2 Asia Pacific Artificial Blood Substitute Revenue by Type (2018-2027)
    8.2 Asia Pacific Artificial Blood Substitute Market Size by Application
        8.2.1 Asia Pacific Artificial Blood Substitute Sales by Application (2018-2027)
        8.2.2 Asia Pacific Artificial Blood Substitute Revenue by Application (2018-2027)
    8.3 Asia Pacific Artificial Blood Substitute Market Size by Region
        8.3.1 Asia Pacific Artificial Blood Substitute Sales by Region (2018-2027)
        8.3.2 Asia Pacific Artificial Blood Substitute Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Artificial Blood Substitute Market Size by Type
        9.1.1 Latin America Artificial Blood Substitute Sales by Type (2019-2027)
        9.1.2 Latin America Artificial Blood Substitute Revenue by Type (2019-2027)
    9.2 Latin America Artificial Blood Substitute Market Size by Application
        9.2.1 Latin America Artificial Blood Substitute Sales by Application (2019-2027)
        9.2.2 Latin America Artificial Blood Substitute Revenue by Application (2019-2027)
    9.3 Latin America Artificial Blood Substitute Market Size by Country
        9.3.1 Latin America Artificial Blood Substitute Sales by Country (2019-2027)
        9.3.2 Latin America Artificial Blood Substitute Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Artificial Blood Substitute Market Size by Type
        6.1.1 Middle East and Africa Artificial Blood Substitute Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Artificial Blood Substitute Revenue by Type (2016-2027)
    6.2 Middle East and Africa Artificial Blood Substitute Market Size by Application
        6.2.1 Middle East and Africa Artificial Blood Substitute Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Artificial Blood Substitute Revenue by Application (2016-2027)
    6.3 Middle East and Africa Artificial Blood Substitute Market Size by Country
        6.3.1 Middle East and Africa Artificial Blood Substitute Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Artificial Blood Substitute Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 UAE

11 Company Profiles
    11.1 Aurum Biosciences Ltd.
        11.1.1 Aurum Biosciences Ltd. Corporation Information
        11.1.2 Aurum Biosciences Ltd. Overview
        11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Description
        11.1.5 Aurum Biosciences Ltd. Related Developments
    11.2 HEMARINA SA
        11.2.1 HEMARINA SA Corporation Information
        11.2.2 HEMARINA SA Overview
        11.2.3 HEMARINA SA Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 HEMARINA SA Artificial Blood Substitute Product Description
        11.2.5 HEMARINA SA Related Developments
    11.3 HbO2 Therapeutics
        11.3.1 HbO2 Therapeutics Corporation Information
        11.3.2 HbO2 Therapeutics Overview
        11.3.3 HbO2 Therapeutics Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Description
        11.3.5 HbO2 Therapeutics Related Developments
    11.4 KaloCyte Inc.
        11.4.1 KaloCyte Inc. Corporation Information
        11.4.2 KaloCyte Inc. Overview
        11.4.3 KaloCyte Inc. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 KaloCyte Inc. Artificial Blood Substitute Product Description
        11.4.5 KaloCyte Inc. Related Developments
    11.5 SpheriTech Ltd.
        11.5.1 SpheriTech Ltd. Corporation Information
        11.5.2 SpheriTech Ltd. Overview
        11.5.3 SpheriTech Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Description
        11.5.5 SpheriTech Ltd. Related Developments
    11.6 NuvOx Pharma
        11.6.1 NuvOx Pharma Corporation Information
        11.6.2 NuvOx Pharma Overview
        11.6.3 NuvOx Pharma Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 NuvOx Pharma Artificial Blood Substitute Product Description
        11.6.5 NuvOx Pharma Related Developments
    11.1 Aurum Biosciences Ltd.
        11.1.1 Aurum Biosciences Ltd. Corporation Information
        11.1.2 Aurum Biosciences Ltd. Overview
        11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Description
        11.1.5 Aurum Biosciences Ltd. Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Artificial Blood Substitute Value Chain Analysis
    12.2 Artificial Blood Substitute Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Artificial Blood Substitute Production Mode & Process
    12.4 Artificial Blood Substitute Sales and Marketing
        12.4.1 Artificial Blood Substitute Sales Channels
        12.4.2 Artificial Blood Substitute Distributors
    12.5 Artificial Blood Substitute Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Artificial Blood Substitute Industry Trends
    13.2 Artificial Blood Substitute Market Drivers
    13.3 Artificial Blood Substitute Market Challenges
    13.4 Artificial Blood Substitute Market Restraints

14 Key Findings in The Global Artificial Blood Substitute Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Artificial Blood Substitute Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Perfluorocarbon-based Oxygen Carrier (PFBOC)
    Table 3. Major Manufacturers of Hemoglobin-based Oxygen Carrier (HBOC)
    Table 4. Global Artificial Blood Substitute Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 5. Global Artificial Blood Substitute Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Artificial Blood Substitute Sales by Region (2016-2021) & (Kilotons)
    Table 7. Global Artificial Blood Substitute Sales Market Share by Region (2016-2021)
    Table 8. Global Artificial Blood Substitute Sales by Region (2016-2021) & (Kilotons)
    Table 9. Global Artificial Blood Substitute Sales Market Share by Region (2022-2027)
    Table 10. Global Artificial Blood Substitute Revenue by Region (2016-2021) & (US$ Million)
    Table 11. Global Artificial Blood Substitute Revenue Market Share by Region (2016-2021)
    Table 12. Global Artificial Blood Substitute Revenue by Region (2022-2027) & (US$ Million)
    Table 13. Global Artificial Blood Substitute Revenue Market Share by Region (2022-2027)
    Table 14. Global Artificial Blood Substitute Sales by Manufacturers (2016-2021) & (Kilotons)
    Table 15. Global Artificial Blood Substitute Sales Share by Manufacturers (2016-2021)
    Table 16. Global Artificial Blood Substitute Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 17. Global Artificial Blood Substitute Revenue Share by Manufacturers (2016-2021)
    Table 18. Artificial Blood Substitute Price by Manufacturers 2016-2021 (US$/Ton)
    Table 19. Global Artificial Blood Substitute Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Substitute as of 2020)
    Table 21. Artificial Blood Substitute Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Artificial Blood Substitute Product Offered
    Table 23. Date of Manufacturers Enter into Artificial Blood Substitute Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Artificial Blood Substitute Sales by Type (2016-2021) & (Kilotons)
    Table 26. Global Artificial Blood Substitute Sales by Type (2022-2027) & (Kilotons)
    Table 27. Global Artificial Blood Substitute Sales Share by Type (2016-2021)
    Table 28. Global Artificial Blood Substitute Sales Share by Type (2022-2027)
    Table 29. Global Artificial Blood Substitute Revenue by Type (2016-2021) & (US$ Million)
    Table 30. Global Artificial Blood Substitute Revenue by Type (2022-2027) & (US$ Million)
    Table 31. Global Artificial Blood Substitute Revenue Share by Type (2016-2021)
    Table 32. Global Artificial Blood Substitute Revenue Share by Type (2022-2027)
    Table 33. Artificial Blood Substitute Price by Type (2016-2021) & (US$/Ton)
    Table 34. Global Artificial Blood Substitute Price Forecast by Type (2022-2027) & (US$/Ton)
    Table 35. Global Artificial Blood Substitute Sales by Application (2016-2021) & (Kilotons)
    Table 36. Global Artificial Blood Substitute Sales by Application (2022-2027) & (Kilotons)
    Table 37. Global Artificial Blood Substitute Sales Share by Application (2016-2021)
    Table 38. Global Artificial Blood Substitute Sales Share by Application (2022-2027)
    Table 39. Global Artificial Blood Substitute Revenue by Application (2016-2021) & (US$ Million)
    Table 40. Global Artificial Blood Substitute Revenue by Application (2022-2027) & (US$ Million)
    Table 41. Global Artificial Blood Substitute Revenue Share by Application (2016-2021)
    Table 42. Global Artificial Blood Substitute Revenue Share by Application (2022-2027)
    Table 43. Artificial Blood Substitute Price by Application (2016-2021) & (US$/Ton)
    Table 44. Global Artificial Blood Substitute Price Forecast by Application (2022-2027) & (US$/Ton)
    Table 45. North America Artificial Blood Substitute Sales by Type (2016-2021) & (Kilotons)
    Table 46. North America Artificial Blood Substitute Sales by Type (2022-2027) & (Kilotons)
    Table 47. North America Artificial Blood Substitute Revenue by Type (2016-2021) & (US$ Million)
    Table 48. North America Artificial Blood Substitute Revenue by Type (2022-2027) & (US$ Million)
    Table 49. North America Artificial Blood Substitute Sales by Application (2016-2021) & (Kilotons)
    Table 50. North America Artificial Blood Substitute Sales by Application (2022-2027) & (Kilotons)
    Table 51. North America Artificial Blood Substitute Revenue by Application (2016-2021) & (US$ Million)
    Table 52. North America Artificial Blood Substitute Revenue by Application (2022-2027) & (US$ Million)
    Table 53. North America Artificial Blood Substitute Sales by Country (2016-2021) & (Kilotons)
    Table 54. North America Artificial Blood Substitute Sales by Country (2022-2027) & (Kilotons)
    Table 55. North America Artificial Blood Substitute Revenue by Country (2016-2021) & (US$ Million)
    Table 56. North America Artificial Blood Substitute Revenue by Country (2022-2027) & (US$ Million)
    Table 57. Europe Artificial Blood Substitute Sales by Type (2016-2021) & (Kilotons)
    Table 58. Europe Artificial Blood Substitute Sales by Type (2022-2027) & (Kilotons)
    Table 59. Europe Artificial Blood Substitute Revenue by Type (2016-2021) & (US$ Million)
    Table 60. Europe Artificial Blood Substitute Revenue by Type (2022-2027) & (US$ Million)
    Table 61. Europe Artificial Blood Substitute Sales by Application (2016-2021) & (Kilotons)
    Table 62. Europe Artificial Blood Substitute Sales by Application (2022-2027) & (Kilotons)
    Table 63. Europe Artificial Blood Substitute Revenue by Application (2016-2021) & (US$ Million)
    Table 64. Europe Artificial Blood Substitute Revenue by Application (2022-2027) & (US$ Million)
    Table 65. Europe Artificial Blood Substitute Sales by Country (2016-2021) & (Kilotons)
    Table 66. Europe Artificial Blood Substitute Sales by Country (2022-2027) & (Kilotons)
    Table 67. Europe Artificial Blood Substitute Revenue by Country (2016-2021) & (US$ Million)
    Table 68. Europe Artificial Blood Substitute Revenue by Country (2022-2027) & (US$ Million)
    Table 69. Asia Pacific Artificial Blood Substitute Sales by Type (2016-2021) & (Kilotons)
    Table 70. Asia Pacific Artificial Blood Substitute Sales by Type (2022-2027) & (Kilotons)
    Table 71. Asia Pacific Artificial Blood Substitute Revenue by Type (2016-2021) & (US$ Million)
    Table 72. Asia Pacific Artificial Blood Substitute Revenue by Type (2022-2027) & (US$ Million)
    Table 73. Asia Pacific Artificial Blood Substitute Sales by Application (2016-2021) & (Kilotons)
    Table 74. Asia Pacific Artificial Blood Substitute Sales by Application (2022-2027) & (Kilotons)
    Table 75. Asia Pacific Artificial Blood Substitute Revenue by Application (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Artificial Blood Substitute Revenue by Application (2022-2027) & (US$ Million)
    Table 77. Asia Pacific Artificial Blood Substitute Sales by Region (2016-2021) & (Kilotons)
    Table 78. Asia Pacific Artificial Blood Substitute Sales by Region (2022-2027) & (Kilotons)
    Table 79. Asia Pacific Artificial Blood Substitute Revenue by Region (2016-2021) & (US$ Million)
    Table 80. Asia Pacific Artificial Blood Substitute Revenue by Region (2022-2027) & (US$ Million)
    Table 81. Latin America Artificial Blood Substitute Sales by Type (2016-2021) & (Kilotons)
    Table 82. Latin America Artificial Blood Substitute Sales by Type (2022-2027) & (Kilotons)
    Table 83. Latin America Artificial Blood Substitute Revenue by Type (2016-2021) & (US$ Million)
    Table 84. Latin America Artificial Blood Substitute Revenue by Type (2022-2027) & (US$ Million)
    Table 85. Latin America Artificial Blood Substitute Sales by Application (2016-2021) & (Kilotons)
    Table 86. Latin America Artificial Blood Substitute Sales by Application (2022-2027) & (Kilotons)
    Table 87. Latin America Artificial Blood Substitute Revenue by Application (2016-2021) & (US$ Million)
    Table 88. Latin America Artificial Blood Substitute Revenue by Application (2022-2027) & (US$ Million)
    Table 89. Latin America Artificial Blood Substitute Sales by Country (2016-2021) & (Kilotons)
    Table 90. Latin America Artificial Blood Substitute Sales by Country (2022-2027) & (Kilotons)
    Table 91. Latin America Artificial Blood Substitute Revenue by Country (2016-2021) & (US$ Million)
    Table 92. Latin America Artificial Blood Substitute Revenue by Country (2022-2027) & (US$ Million)
    Table 93. Middle East and Africa Artificial Blood Substitute Sales by Type (2016-2021) & (Kilotons)
    Table 94. Middle East and Africa Artificial Blood Substitute Sales by Type (2022-2027) & (Kilotons)
    Table 95. Middle East and Africa Artificial Blood Substitute Revenue by Type (2016-2021) & (US$ Million)
    Table 96. Middle East and Africa Artificial Blood Substitute Revenue by Type (2022-2027) & (US$ Million)
    Table 97. Middle East and Africa Artificial Blood Substitute Sales by Application (2016-2021) & (Kilotons)
    Table 98. Middle East and Africa Artificial Blood Substitute Sales by Application (2022-2027) & (Kilotons)
    Table 99. Middle East and Africa Artificial Blood Substitute Revenue by Application (2016-2021) & (US$ Million)
    Table 100. Middle East and Africa Artificial Blood Substitute Revenue by Application (2022-2027) & (US$ Million)
    Table 101. Middle East and Africa Artificial Blood Substitute Sales by Country (2016-2021) & (Kilotons)
    Table 102. Middle East and Africa Artificial Blood Substitute Sales by Country (2022-2027) & (Kilotons)
    Table 103. Middle East and Africa Artificial Blood Substitute Revenue by Country (2016-2021) & (US$ Million)
    Table 104. Middle East and Africa Artificial Blood Substitute Revenue by Country (2022-2027) & (US$ Million)
    Table 105. Aurum Biosciences Ltd. Corporation Information
    Table 106. Aurum Biosciences Ltd. Description and Major Businesses
    Table 107. Aurum Biosciences Ltd. Artificial Blood Substitute Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 108. Aurum Biosciences Ltd. Artificial Blood Substitute Product
    Table 109. Aurum Biosciences Ltd. Recent Developments
    Table 110. HEMARINA SA Corporation Information
    Table 111. HEMARINA SA Description and Major Businesses
    Table 112. HEMARINA SA Artificial Blood Substitute Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 113. HEMARINA SA Artificial Blood Substitute Product
    Table 114. HEMARINA SA Recent Developments
    Table 115. HbO2 Therapeutics Corporation Information
    Table 116. HbO2 Therapeutics Description and Major Businesses
    Table 117. HbO2 Therapeutics Artificial Blood Substitute Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 118. HbO2 Therapeutics Artificial Blood Substitute Product
    Table 119. HbO2 Therapeutics Recent Developments
    Table 120. KaloCyte Inc. Corporation Information
    Table 121. KaloCyte Inc. Description and Major Businesses
    Table 122. KaloCyte Inc. Artificial Blood Substitute Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 123. KaloCyte Inc. Artificial Blood Substitute Product
    Table 124. KaloCyte Inc. Recent Developments
    Table 125. SpheriTech Ltd. Corporation Information
    Table 126. SpheriTech Ltd. Description and Major Businesses
    Table 127. SpheriTech Ltd. Artificial Blood Substitute Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 128. SpheriTech Ltd. Artificial Blood Substitute Product
    Table 129. SpheriTech Ltd. Recent Developments
    Table 130. NuvOx Pharma Corporation Information
    Table 131. NuvOx Pharma Description and Major Businesses
    Table 132. NuvOx Pharma Artificial Blood Substitute Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 133. NuvOx Pharma Artificial Blood Substitute Product
    Table 134. NuvOx Pharma Recent Developments
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Artificial Blood Substitute Distributors List
    Table 138. Artificial Blood Substitute Customers List
    Table 139. Artificial Blood Substitute Market Trends
    Table 140. Artificial Blood Substitute Market Drivers
    Table 141. Artificial Blood Substitute Market Challenges
    Table 142. Artificial Blood Substitute Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Artificial Blood Substitute Product Picture
    Figure 2. Global Artificial Blood Substitute Market Share by Type in 2020 & 2027
    Figure 3. Perfluorocarbon-based Oxygen Carrier (PFBOC) Product Picture
    Figure 4. Hemoglobin-based Oxygen Carrier (HBOC) Product Picture
    Figure 5. Global Artificial Blood Substitute Sales Market Share by Application in 2020 & 2027
    Figure 6. Military
    Figure 7. Civil
    Figure 8. Artificial Blood Substitute Report Years Considered
    Figure 9. Global Artificial Blood Substitute Sales 2016-2027 (Kilotons)
    Figure 10. Global Artificial Blood Substitute Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Artificial Blood Substitute Revenue 2016-2027 (US$ Million)
    Figure 12. Global Artificial Blood Substitute Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 13. Global Artificial Blood Substitute Sales Market Share by Region (2016-2021)
    Figure 14. Global Artificial Blood Substitute Sales Market Share by Region (2022-2027)
    Figure 15. North America Artificial Blood Substitute Sales YoY (2016-2027) & (Kilotons)
    Figure 16. North America Artificial Blood Substitute Revenue YoY (2016-2027) & (US$ Million)
    Figure 17. Europe Artificial Blood Substitute Sales YoY (2016-2027) & (Kilotons)
    Figure 18. Europe Artificial Blood Substitute Revenue YoY (2016-2027) & (US$ Million)
    Figure 19. Asia-Pacific Artificial Blood Substitute Sales YoY (2016-2027) & (Kilotons)
    Figure 20. Asia-Pacific Artificial Blood Substitute Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Latin America Artificial Blood Substitute Sales YoY (2016-2027) & (Kilotons)
    Figure 22. Latin America Artificial Blood Substitute Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Middle East & Africa Artificial Blood Substitute Sales YoY (2016-2027) & (Kilotons)
    Figure 24. Middle East & Africa Artificial Blood Substitute Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. The Top 10 and Top 5 Players Market Share by Artificial Blood Substitute Sales in 2020
    Figure 26. The Top 10 and Top 5 Players Market Share by Artificial Blood Substitute Revenue in 2020
    Figure 27. Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 28. Global Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    Figure 29. Global Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    Figure 30. Global Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    Figure 31. Global Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    Figure 32. North America Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    Figure 33. North America Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    Figure 34. North America Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    Figure 35. North America Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    Figure 36. North America Artificial Blood Substitute Sales Share by Country (2016-2027)
    Figure 37. North America Artificial Blood Substitute Revenue Share by Country (2016-2027)
    Figure 38. U.S. Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 39. Canada Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 40. Europe Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    Figure 41. Europe Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    Figure 42. Europe Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    Figure 43. Europe Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    Figure 44. Europe Artificial Blood Substitute Sales Share by Country (2016-2027)
    Figure 45. Europe Artificial Blood Substitute Revenue Share by Country (2016-2027)
    Figure 46. Germany Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 47. France Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 48. U.K. Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 49. Italy Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 50. Russia Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 51. Asia Pacific Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    Figure 52. Asia Pacific Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    Figure 53. Asia Pacific Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    Figure 54. Asia Pacific Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    Figure 55. Asia Pacific Artificial Blood Substitute Sales Share by Region (2016-2027)
    Figure 56. Asia Pacific Artificial Blood Substitute Revenue Share by Region (2016-2027)
    Figure 57. China Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 58. Japan Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 59. South Korea Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 60. India Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 61. Australia Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 62. Taiwan Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 63. Indonesia Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 64. Thailand Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 65. Malaysia Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 66. Philippines Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 67. Latin America Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    Figure 68. Latin America Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    Figure 69. Latin America Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    Figure 70. Latin America Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    Figure 71. Latin America Artificial Blood Substitute Sales Share by Country (2016-2027)
    Figure 72. Latin America Artificial Blood Substitute Revenue Share by Country (2016-2027)
    Figure 73. Mexico Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 74. Brazil Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 75. Argentina Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 76. Middle East and Africa Artificial Blood Substitute Sales Market Share by Type (2016-2027)
    Figure 77. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
    Figure 78. Middle East and Africa Artificial Blood Substitute Sales Market Share by Application (2016-2027)
    Figure 79. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
    Figure 80. Middle East and Africa Artificial Blood Substitute Sales Share by Country (2016-2027)
    Figure 81. Middle East and Africa Artificial Blood Substitute Revenue Share by Country (2016-2027)
    Figure 82. Turkey Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 83. Saudi Arabia Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 84. UAE Artificial Blood Substitute Revenue (2016-2027) & (US$ Million)
    Figure 85. Artificial Blood Substitute Value Chain
    Figure 86. Artificial Blood Substitute Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Frequently Asked Questions
Artificial Blood Substitute report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Artificial Blood Substitute report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Artificial Blood Substitute report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

D-lactic Acid

D-lactic Acid market is segmented by Type, and by Application. Players, stakeholders, and other p ... Read More

Pentanediamine

Pentanediamine market is segmented by Type, and by Application. Players, stakeholders, and other  ... Read More